Fesarius Therapeutics
Brooklyn
About Fesarius Therapeutics
Fesarius Therapeutics is a biotechnology company that intends to develop and sell modified skin replacement products. To create a line of engineered tissue goods, developed a tissue engineering technique based on IP for microsphere-containing hydrogels. The company's method uses microspheres embedded in a collagen hydrogel to enhance the number of differential density interfaces that drive cell invasion into the scaffold, allowing patients to heal from trauma, burns, or infection at an affordable cost.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.6M
- Funding stage: Seed
- Last round: Grant (Aug 2023)
- Website: fesariustherapeutics.com
- Phone: +1 917 589 4850
Industries & Categories
Biotechnology, Cosmetics, Life Science, Manufacturing, Sales
Social Profiles
Canonical: https://fsome.com/organization/fesarius-therapeutics-23605 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.